Fair Value Measurements (Tables)
|
6 Months Ended |
Jun. 30, 2024 |
| Fair Value Disclosures [Abstract] |
|
| Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis |
Our financial assets and (liabilities) carried at fair value and measured on a recurring basis as of June 30, 2024 and December 31, 2023 consisted of the following (in thousands): | | | | | | | | | | | | | | | | | | Fair Value Measurements Using | | | Total Fair | | Quoted prices in | | Significant other | | Significant | | | Value at | | active markets | | observable inputs | | unobservable inputs | | | June 30, 2024 | | (Level 1) | | (Level 2) | | (Level 3) | Marketable securities (1) | | $ | 61 | | $ | 61 | | $ | — | | $ | — | Interest rate contract asset, current (2) | | $ | 254 | | $ | — | | $ | 254 | | $ | — | Foreign currency contract assets, current and long-term (3) | | $ | 4,946 | | $ | — | | $ | 4,946 | | $ | — | Foreign currency contract liabilities, current and long-term (4) | | $ | (2,250) | | $ | — | | $ | (2,250) | | $ | — | Contingent consideration liabilities | | $ | (3,435) | | $ | — | | $ | — | | $ | (3,435) |
| | | | | | | | | | | | | | | | | | Fair Value Measurements Using | | | Total Fair | | Quoted prices in | | Significant other | | Significant | | | Value at | | active markets | | observable inputs | | unobservable inputs | | | December 31, 2023 | | (Level 1) | | (Level 2) | | (Level 3) | Marketable securities (1) | | $ | 78 | | $ | 78 | | $ | — | | | — | Interest rate contract asset, current (2) | | $ | 1,503 | | $ | — | | $ | 1,503 | | $ | — | Foreign currency contract assets, current and long-term (3) | | $ | 3,105 | | $ | — | | $ | 3,105 | | $ | — | Foreign currency contract liabilities, current and long-term (4) | | $ | (3,860) | | $ | — | | $ | (3,860) | | $ | — | Contingent consideration liabilities | | $ | (3,447) | | $ | — | | $ | — | | $ | (3,447) |
| (1) | Our marketable securities, which consist entirely of available-for-sale equity securities, are valued using market prices in active markets. Level 1 instrument valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets. |
| (2) | The fair value of the interest rate contract is determined using Level 2 fair value inputs and is recorded as prepaid and other current assets in the consolidated balance sheets. |
| (3) | The fair value of the foreign currency contract assets (including those designated as hedging instruments and those not designated as hedging instruments) is determined using Level 2 fair value inputs and is recorded as a prepaid expense and other current asset or other long-term asset in the consolidated balance sheets. |
| (4) | The fair value of the foreign currency contract liabilities (including those designated as hedging instruments and those not designated as hedging instruments) is determined using Level 2 fair value inputs and is recorded as accrued expense or other long-term obligation in the consolidated balance sheets. |
|
| Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation |
Changes in the fair value of our contingent consideration liabilities during the three and six-month periods ended June 30, 2024 and 2023 consisted of the following (in thousands): | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | June 30, | | June 30, | | | 2024 | | 2023 | | 2024 | | 2023 | Beginning balance | | $ | 3,225 | | $ | 16,000 | | $ | 3,447 | | $ | 18,073 | Contingent consideration expense | | | 305 | | | 1,094 | | | 188 | | | 1,615 | Contingent payments made | | | (95) | | | (13,513) | | | (200) | | | (16,107) | Ending balance | | $ | 3,435 | | $ | 3,581 | | $ | 3,435 | | $ | 3,581 |
|
| Fair Value Inputs, Liabilities, Quantitative Information |
The recurring Level 3 measurement of our contingent consideration liabilities included the following significant unobservable inputs at June 30, 2024 and December 31, 2023 (amounts in thousands): | | | | | | | | | | | | | | Fair value at | | | | | | | | | | | June 30, | | Valuation | | | | | | Weighted | Contingent consideration liability | | 2024 | | technique | | Unobservable inputs | | Range | | Average(1) | Revenue-based royalty payments contingent liability | | $ | 2,937 | | Discounted cash flow | | Discount rate | | 12% - 16% | | 14.6% | | | | | | | | Projected year of payments | | 2024-2034 | | 2028 | | | | | | | | | | | | | Revenue milestones contingent liability | | $ | 91 | | Monte Carlo simulation | | Discount rate | | 13.0% | | | | | | | | | | Projected year of payments | | 2024-2040 | | 2040 | | | | | | | | | | | | | Regulatory approval contingent liability | | $ | 407 | | Scenario-based method | | Discount rate | | 6.1% | | | | | | | | | | Probability of milestone payment | | 50.0% | | | | | | | | | | Projected year of payment | | 2024-2030 | | 2030 |
| | | | | | | | | | | | | | Fair value at | | | | | | | | | | | December 31, | | Valuation | | | | | | Weighted | Contingent consideration liability | | 2023 | | technique | | Unobservable inputs | | Range | | Average(1) | Revenue-based royalty payments contingent liability | | $ | 2,945 | | Discounted cash flow | | Discount rate | | 12.0% - 16.0% | | 14.6% | | | | | | | | Projected year of payments | | 2024-2034 | | 2028 | | | | | | | | | | | | | Revenue milestones contingent liability | | $ | 93 | | Monte Carlo simulation | | Discount rate | | 13.0% | | | | | | | | | | Projected year of payments | | 2024-2039 | | 2039 | | | | | | | | | | | | | Regulatory approval contingent liability | | $ | 409 | | Scenario-based method | | Discount rate | | 5.5% | | | | | | | | | | Probability of milestone payment | | 50.0% | | | | | | | | | | Projected year of payment | | 2024-2030 | | 2030 |
| (1) | Unobservable inputs were weighted by the relative fair value of the instruments. No weighted average is reported for contingent consideration liabilities without a range of unobservable inputs. |
|
| Schedule of Rollforward of Allowance for Credit Losses |
The table below presents a roll-forward of the allowance for current expected credit losses on our notes receivable for the three and six-month periods ended June 30, 2024 and 2023 (in thousands): | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | June 30, | | June 30, | | | 2024 | | 2023 | | 2024 | | 2023 | Beginning balance | | $ | 1,388 | | $ | 290 | | $ | 568 | | $ | 281 | Provision for credit loss expense | | | 18 | | | 6 | | | 838 | | | 15 | Ending balance | | $ | 1,406 | | $ | 296 | | $ | 1,406 | | $ | 296 |
|